ChemicalBook CAS DataBase List FLURAZEPAM

FLURAZEPAM

$20 - $860

Product nameFLURAZEPAM
Cas No17617-23-1
MFC21H23ClFN3O
MW387.88
EINECS241-591-7
MDL NumberMFCD00057324

Price

Brand	Packaging	Price	Product name
AHH MT-51860	5g	$860	Flurazepam
Cayman Chemical 16190	5mg	$60	Flurazepam
Cayman Chemical 18160	1mg	$20	Flurazepam (CRM)
Sigma-Aldrich F-003	1mL	$23.8	Flurazepam solution

Properties

Safety Information

Description

Flurazepam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam (CRM) pam

More related product prices

Send Inquriy

Melting point	77-82°
Boiling point	551.4±50.0 °C(Predicted)
Density	1.2089 (estimate)
Flash point	9℃
storage temp.	2-8°C
solubility	45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: <6 mg/mL
pka	pKa 1.90±0.05(H2O) (Uncertain);8.16±0.05 (Uncertain)
form	solid
color	light yellow
EPA Substance Registry System	2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro- (17617-23-1)